Pandemic Darlings The pandemic economy, in original documents
Home United States District Court for the Western District of Texas — Case 5:17-cv-01249, Document 108Search ⌕

United States District Court for the Western District of Texas — Case 5:17-cv-01249, Document 108

Summary

An Order filed 01/06/22 as Document 108 in United States ex rel. Integra Med Analytics, LLC v. Creative Solutions in Healthcare, Inc., No. SA-17-CV-01249-XR, in the U.S. District Court for the Western District of Texas, San Antonio Division. Judge Xavier Rodriguez considered the parties' joint statement on the status of the first discovery stage (ECF No. 107). The order sets a joint status statement due February 16, 2022 and every 30 days after that, completion of that discovery stage by September 19, 2022, and a proposed scheduling order for the rest of the case by September 23, 2022. It is signed January 6, 2022.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Cite this document

“United States District Court for the Western District of Texas — Case 5:17-cv-01249, Document 108.” Original at ecf.txwd.uscourts.gov. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/court-filing-no-5-17-cv-01249-dkt-108-w-d-tex-a283d8771f/, SHA-256 f1cf326817483e99944ca021f9ac21c35b5cff5d43b407061071a9ffc92f0e02.

Full text

         Case 5:17-cv-01249-XR        Document 108        Filed 01/06/22    Page 1 of 1




                        IN THE UNITED STATES DISTRICT COURT
                         FOR THE WESTERN DISTRICT OF TEXAS
                                SAN ANTONIO DIVISION


UNITED STATES OF AMERICA,                         §
EX.REL INTEGRA MED ANALYTICS,                     §
LLC, RELATOR,                                     §                 SA-17-CV-01249-XR
              Plaintiff,                          §
                                                  §
v.                                                §
                                                  §
CREATIVE SOLUTIONS IN                             §
HEALTHCARE, INC.,                                 §
             Defendant.                           §

                                            ORDER

         On this date, the Court considered the parties’ joint statement on the status of Phase I

discovery. ECF No. 107. The parties propose a deadline of February 16, 2022, “for the next Joint

Statement on Phase 1 Discovery that should include any unresolved discovery disputes.” Id. at 3.

The Court hereby SETS the following deadlines:

     •   Joint statement on the status of Phase I discovery: February 16, 2022, and every 30 days

         thereafter.

     •   Completion of Phase I discovery: September 19, 2022

     •   Proposed scheduling order to govern the remainder of this case: September 23, 2022

         It is so ORDERED.

         SIGNED this January 6, 2022.




                                             XAVIER RODRIGUEZ
                                             UNITED STATES DISTRICT JUDGE


File and source

File
108-first100-v2-rank-40.pdf
Size
171,387 bytes
SHA-256
f1cf326817483e99944ca021f9ac21c35b5cff5d43b407061071a9ffc92f0e02
Our copy
108-first100-v2-rank-40.pdf
Original
PACER (login required)
Back to top